CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+10.48%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.19B
AUM Growth
+$1.19B
(-0.13%)
Cap. Flow
-$93.5M
Cap. Flow
% of AUM
-7.83%
Top 10 Holdings %
Top 10 Hldgs %
55.3%
Holding
49
New
10
Increased
7
Reduced
7
Closed
13
Top Buys
| 1 |
CYBX
CYBERONICS INC
CYBX
|
$48.7M |
| 2 |
Select Medical
SEM
|
$44.5M |
| 3 |
AbbVie
ABBV
|
$43.9M |
| 4 |
MDCO
Medicines Co
MDCO
|
$33.1M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$32.8M |
Top Sells
| 1 |
GSK
GSK
|
$74.8M |
| 2 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
$45.6M |
| 3 |
Viatris
VTRS
|
$42.3M |
| 4 |
CONMED
CNMD
|
$36.1M |
| 5 |
Boston Scientific
BSX
|
$33.1M |
Sector Composition
| 1 | Healthcare | 72.75% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $103M | 7.34% | 1,650,000 -100,000 | -6% | -$6.23M |
|
2
Masimo
MASI
$7.59B
| $89M | 6.36% | 2,700,000 -150,000 | -5% | -$4.95M |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $70.1M | 5% | 2,500,000 +1,180,000 | +89% | +$33.1M |
|
|
GHDX
4
DELISTED
Genomic Health, Inc.
GHDX
| $64.2M | 4.58% | 2,100,000 -50,000 | -2% | -$1.53M |
|
|
ESRX
5
DELISTED
Express Scripts Holding Company
ESRX
| $60.7M | 4.34% | 700,000 | – | – |
|
|
ARIA
6
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $57.7M | 4.12% | 7,000,000 -500,000 | -7% | -$4.12M |
|
|
UAM
7
DELISTED
Universal American Corp
UAM
| $55.9M | 3.99% | 5,234,898 +666,000 | +15% | +$7.11M |
|
|
AMAG
8
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $55.7M | 3.97% | 1,018,246 +18,246 | +2% | +$997K |
|
9
Orthofix Medical
OFIX
$592M
| $53.8M | 3.84% | 1,500,000 +250,000 | +20% | +$8.97M |
|
10
Labcorp
LH
$23.1B
| $50.4M | 3.6% | 400,000 -100,000 | -20% | -$12.6M |
|
|
CYBX
11
DELISTED
CYBERONICS INC
CYBX
| $48.7M | 3.48% | +750,000 | New | +$48.7M |
|
|
12
Select Medical
SEM
$1.61B
| $44.5M | 3.18% | +3,000,000 | New | +$44.5M |
|
|
13
AbbVie
ABBV
$372B
| $43.9M | 3.13% | +750,000 | New | +$43.9M |
|
|
KERX
14
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $38.2M | 2.73% | 3,000,000 | – | – |
|
15
Bruker
BRKR
$5.16B
| $36.9M | 2.64% | 2,000,000 | – | – |
|
|
KND
16
DELISTED
Kindred Healthcare
KND
| $35.7M | 2.55% | 1,500,000 | – | – |
|
|
SQNM
17
DELISTED
SEQUENOM INC NEW
SQNM
| $35.6M | 2.54% | 9,000,000 +250,000 | +3% | +$988K |
|
|
18
CONMED
CNMD
$1.68B
| $33.9M | 2.42% | 670,943 -714,057 | -52% | -$36.1M |
|
|
ARNA
19
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $32.8M | 2.34% | +7,500,000 | New | +$32.8M |
|
|
AMRN
20
Amarin Corp
AMRN
$311M
| $28.1M | 2% | 12,000,000 | – | – |
|
|
GNMK
21
DELISTED
GenMark Diagnostics, Inc
GNMK
| $19.2M | 1.37% | 1,482,662 -265,438 | -15% | -$3.45M |
|
|
TRVN
22
DELISTED
Trevena, Inc.
TRVN
| $18.7M | 1.34% | 2,870,000 | – | – |
|
23
Cross Country Healthcare
CCRN
$438M
| $16.9M | 1.2% | 1,422,565 | – | – |
|
|
EPRS
24
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $16.5M | 1.18% | +1,847,500 | New | +$16.5M |
|
25
Option Care Health
OPCH
$4.65B
| $13.3M | 0.95% | +3,000,000 | New | +$13.3M |
|